What is Enable Injections's business focus and history?
Enable Injections is a funded company based in Cincinnati, Ohio (United States), founded in 2010 by Michael D. Hooven. It operates in the Medical Devices industry, developing and manufacturing the enFuseĀ® On-Body Delivery System for subcutaneous administration of large-volume medications. Enable Injections has raised significant funding, including a $30 million investment from Sanofi in January 2026. The company has multiple office locations in the United States, including Evendale, Springdale, West Chester, and Franklin.
Enable Injections Corporate Details & Core Services
Enable Injections is a healthcare innovation company developing and manufacturing the enFuseĀ® On-Body Delivery System, designed to deliver large volumes of pharmaceutical and biologic therapeutics via subcutaneous administration.
Enable Injections Contact Information & Official Links
What are Enable Injections's Key Business Metrics & Stats?
No of employees
Founded year 2010
Type private
Industry Medical Devices
Location Cincinnati, Ohio, United States
Enable Injections
Firmographic Snapshot
2026
2010
Founded Year
Global Employees
United States
Headquarters
Medical Devices Industry
Private
Type
Verified by
DexterAgent.ai
How much funding has Enable Injections raised to date?
Name
Description
Funding Amount
USD 30 Million
Stage
Series C - II
Latest Valuation
(USD)
Lead Investor
Sanofi
Investors
Sanofi
What are Enable Injections's Core Products?
Name
Description
enFuseĀ®
A wearable drug delivery platform designed to comfortably and conveniently deliver large volumes of medications subcutaneously.
What are the latest developments at Enable Injections?
Date
Type
Description
January, 2026
Investment
Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities
December, 2025
Regulatory Approval
Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELIĀ® Injector based on enFuseĀ® Technology
October, 2025
Partnership
Incyte and Enable Injections Announce Strategic Partnership for enFuseĀ® On-Body Delivery System
What industry awards and recognitions has Enable Injections received?
Date
Type
Description
, 2020
Innovation Award
2020 Innovation and Technology Award from the Business Courier
What are Enable Injections's official legal and registration details?
Name
Description
Legal Name
Enable Injections, Inc.
Cin number
GST number
Registration number
Who is in Enable Injections's executive leadership team?
Name
Designation
CEO
Michael D. Hooven
Executive Vice President and Chief Commercial Officer
Matt Huddleston
Executive Vice President and Chief Financial Officer
Tim Flaherty
Senior Vice President, Human Resources and Strategic Growth
Tiffany Khodadad
Associate Vice President of Quality and Regulatory
Mark Ramser
Senior Vice President, Expansion Strategy and Medical Education
Eileen Rogers
Where are Enable Injections's primary office locations?
City
Country
Evendale
United States
Springdale
United States
West Chester
United States
Franklin
United States
What are the current business signals and market intelligence for Enable Injections?
Type of customer
Pharmaceutical Companies, Biotechnology Companies
Key customer domain
What are Enable Injections's risk management and compliance ratings?
GDPR RIsk
No
Privacy Risk
No
Company Ratings
Glassdoor Rating
Saas
No
Offline Stores
No
Service
No
Ecommerce
No
Exporter
No
Mobile App
No
Retail
No
B2B
Yes
B2C
No
Manufacturing
Yes
Wholesale
No
Importer
No
